An Italian Expert Consensus on the Use of Opioids for the Management of Chronic Non-Oncological Pain in Clinical Practice: Focus on Buprenorphine.
Consalvo MattiaLivio LuongoMassimo InnamoratoLuca MelisMichele SofiaLucia ZappiFilomena PuntilloPublished in: Journal of pain research (2021)
Most of the proposed items reached consensus, suggesting a generally homogeneous approach to CNCP management. However, the lack of consensus recorded for several items regarding opioid use confirms the need to fill important gaps in the knowledge of available agents. A clear explanation of the peculiar pharmacological properties of drugs associated with potential clinical advantages (such as buprenorphine) will help optimize pain treatment in both primary care and hospital settings and improving pain control in CNCP patients.
Keyphrases
- chronic pain
- pain management
- clinical practice
- primary care
- neuropathic pain
- healthcare
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prostate cancer
- prognostic factors
- emergency department
- risk assessment
- radical prostatectomy
- combination therapy
- patient reported outcomes
- replacement therapy